BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Philippou Y, Sjoberg H, Lamb AD, Camilleri P, Bryant RJ. Harnessing the potential of multimodal radiotherapy in prostate cancer. Nat Rev Urol 2020;17:321-38. [DOI: 10.1038/s41585-020-0310-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Fan Y, Fan H, Quan Z, Wu X. Ionizing Radiation Combined with PARP1 Inhibitor Reduces Radioresistance in Prostate Cancer with RB1/TP53 Loss. Cancer Invest 2021;39:423-34. [PMID: 33683975 DOI: 10.1080/07357907.2021.1899200] [Reference Citation Analysis]
2 Chen X, Zeh HJ, Kang R, Kroemer G, Tang D. Cell death in pancreatic cancer: from pathogenesis to therapy. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34331036 DOI: 10.1038/s41575-021-00486-6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Poon DJJ, Tay LM, Ho D, Chua MLK, Chow EK, Yeo ELL. Improving the therapeutic ratio of radiotherapy against radioresistant cancers: Leveraging on novel artificial intelligence-based approaches for drug combination discovery. Cancer Lett 2021;511:56-67. [PMID: 33933554 DOI: 10.1016/j.canlet.2021.04.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Sjoberg HT, Philippou Y, Magnussen AL, Tullis IDC, Bridges E, Chatrian A, Lefebvre J, Tam KH, Murphy EA, Rittscher J, Preise D, Agemy L, Yechezkel T, Smart SC, Kinchesh P, Gilchrist S, Allen DP, Scheiblin DA, Lockett SJ, Wink DA, Lamb AD, Mills IG, Harris A, Muschel RJ, Vojnovic B, Scherz A, Hamdy FC, Bryant RJ. Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer. Br J Cancer 2021;125:534-46. [PMID: 34155340 DOI: 10.1038/s41416-021-01450-6] [Reference Citation Analysis]
5 Yi X, Shen M, Liu X, Gu J, Jiang Z, Xu L, Yang K. Diagnostic Radionuclides Labeled on Biomimetic Nanoparticles for Enhanced Follow-Up Photothermal Therapy of Cancer. Adv Healthc Mater 2021;10:e2100860. [PMID: 34263561 DOI: 10.1002/adhm.202100860] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gallazzi M, Baci D, Mortara L, Bosi A, Buono G, Naselli A, Guarneri A, Dehò F, Capogrosso P, Albini A, Noonan DM, Bruno A. Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors. Front Immunol 2020;11:586126. [PMID: 33569050 DOI: 10.3389/fimmu.2020.586126] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]